Oman Ministry of Health Circular No. 129/2025
Short-Acting Beta 2 Agonists (SABA) (Salbutamol and Terbutaline): Reminder of the Risks From Overuse in Asthma and to Be Aware of Changes in the SABA Prescribing Guidelines
To:
Pharmacist ln charge, Armed Forces Hospital (Al Khoudh & Salalah)
Director of Pharmaceutical Care, Royal Hospital
Director of Pharmaceutical Care, Khoula Hospital
Pharmacist ln charge, Al Nahda Hospital
Director of Pharmaceutical Care, DGHS, Muscat Governorate
Director of Pharmaceutical Care, DGHS, Al Dakhliya Governroate
Director of Pharmaceutical Care, DGHS, South Batinah Governorate
Director of Pharmaceutical Care, DGHS, North Batinah Governorate
Director of Pharmaceutical Care, DGHS, Al Dhahira Governorate
Director of Pharmaceutical Care, DGHS, North Sharqiya Governorate
Director of Pharmaceutical Care, DGHS, South Sharqiya Governorate
Director of Pharmaceutical Care, DGHS, Musandam Governorate
Director of Pharmaceutical Care, DGHS, Dhofar Governorate
Director of Pharmaceutical Care, DGHS, Al Wusta Governorate
Director of Pharmaceutical Care, DGHS, Buraimi Governorate
Director of Pharmaceutical Care, DGMS
Pharmacist lncharge, Al Massarah Hospital
HOD, Pharmacy Department, Sultan Qaboos University Hospital
Pharmacist lncharge, Royal Oman Police
Pharmacist lncharge, The Diwan
Pharmacist lncharge, The Sultan's Special Force
Pharmacist lncharge, Internal Security Services
Pharmacist lncharge, Petroleum Development of Oman
Pharmacist lncharge, LNG Oman
After Compliments,